Latest Breaking News On - Centessa pharmaceuticals - Page 4 : comparemela.com

Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10 00

Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Karenm andersonHarris rotmanNews ratings for centessa pharmaceuticals dailySecurities exchange commissionCentessa pharmaceuticals stock downCentessa pharmaceuticalsInstitutional investors weigh in on centessa pharmaceuticalsRathbones groupJump financialChina universal asset management coAnalyst recommendations for centessa pharmaceuticalsGet free reportExchange commissionUniversal asset managementPharmaceuticals stock downGet free

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesNew yorkDennis riedlKristenk sheppardExchange commissionCapital markets corpEquity syndicate departmentEvercore groupGoldman sachsCentessa pharmaceuticalsDepositary sharesLeerink partnersGuggenheim securitiesEquity capital markets

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering Of American Depositary Shares

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering Of American Depositary Shares
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkCity ofUnited kingdomGoldman sachsCentessa pharmaceuticalsExchange commissionGoldman sachs coLeerink partnersProspectus departmentSyndicate departmentAmerican depositary sharesGuggenheim securitiesAnnual reportQuarterly reports

Centessa Pharmaceuticals Announces Pricing of $100 Million

Centessa Pharmaceuticals Announces Pricing of $100 Million
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomNew yorkKristenk sheppardProspectus departmentEvercore groupEquity syndicate departmentCapital markets corpGuggenheim securitiesCentessa pharmaceuticalsGoldman sachsSyndicate departmentExchange commissionLeerink partnersGoldman sachs co

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomNew yorkKristenk sheppardGuggenheim securitiesCapital markets corpGoldman sachsSyndicate departmentLeerink partnersProspectus departmentEvercore groupCentessa pharmaceuticalsGoldman sachs coEquity syndicate departmentExchange commission